Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Launched by BRIGHAM AND WOMEN'S HOSPITAL · Mar 18, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a special program called PATH, which focuses on positive psychology, can help people who have survived a hematopoietic stem cell transplant (HSCT). The study aims to see if this program can reduce feelings of anxiety and depression and improve the overall quality of life for these survivors compared to those receiving standard care.

To participate, you need to be an adult (18 years or older) who has had an allogeneic HSCT and is nearing 100 days after the transplant. You should be able to communicate in English or Spanish and have access to a regular telephone. However, if your transplant was for a non-cancerous blood condition, or if you have severe mental health issues that would prevent you from understanding the study, you may not be eligible. Participants can expect to engage in the positive psychology program and share their experiences, which may help improve support for future survivors. The study is currently looking for volunteers, so this is a great opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
• • Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
• • Access to a basic telephone
• Exclusion Criteria:
• • Patients who underwent allogeneic HSCT for benign hematologic conditions
• • Patients who received outpatient HSCT
• • Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures